Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluating Symptom Management Educational Materials for Patients With Prostate Cancer
This study has been completed.
First Received: October 8, 2008   Last Updated: May 1, 2009   History of Changes
Sponsored by: Baylor College of Medicine
Information provided by: National Cancer Institute (NCI)
ClinicalTrials.gov Identifier: NCT00769431
  Purpose

RATIONALE: Collecting feedback from patients with prostate cancer may help doctors develop better symptom management educational materials for patients.

PURPOSE: This clinical trial is evaluating symptom management educational materials for patients with prostate cancer.


Condition Intervention
Prostate Cancer
Other: educational intervention
Procedure: study of socioeconomic and demographic variables

MedlinePlus related topics: Cancer Palliative Care Prostate Cancer
U.S. FDA Resources
Study Type: Interventional
Official Title: FOCUS GROUP EVALUATION OF PROSTATE CANCER SYMPTOM MANAGEMENT EDUCATION MATERIALS

Further study details as provided by National Cancer Institute (NCI):

Primary Outcome Measures:
  • Acceptability of the written patient educational materials, in terms of text size, white space, font, and graphics [ Designated as safety issue: No ]
  • Formative evaluation of the new educational materials, in terms of the comments made by the focus group participants [ Designated as safety issue: No ]
  • Validation that the goals of the educational-intervention instruction are being achieved [ Designated as safety issue: No ]
  • Improvement of the educational-intervention instruction by identification and remediation of problems [ Designated as safety issue: No ]

Estimated Enrollment: 30
Study Start Date: May 2008
Primary Completion Date: April 2009 (Final data collection date for primary outcome measure)
Detailed Description:

OBJECTIVES:

  • To collect formative evaluation data about a new educational intervention using focus groups of patients with prostate cancer.
  • To use the focus group data in the master's research paper of a Baylor College of Medicine physician-assistant student who is documenting the process of organizing and conducting the focus groups, enumerating areas where the new materials are deemed problematic, and identifying themes in the comments made by the focus group participants.

OUTLINE: Study participants are assigned to 1 of 3 focus groups according to educational level and ethnicity (i.e., lower educational-level African-American men primarily from the Michael E. DeBakey Veterans Affairs Medical Center (MEDVAMC); lower educational-level Caucasian men from MEDVAMC, Baylor College of Medicine (BCM), or the community; or higher educational-level Caucasian men primarily from BCM or the community).

Participants review written patient educational-intervention materials on prostate cancer and provide feedback to the investigator on the content and acceptability of these materials during a 1½-2-hour focus group discussion. Feedback data are used to revise the intervention materials so that they are appropriate to the target population.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

DISEASE CHARACTERISTICS:

  • Biopsy-proven prostate cancer

    • Localized disease that has been previously treated
  • Selected for participation from 1 of the following:

    • Convenience sample of men from the Baylor College of Medicine (BCM) Urology clinics at Scurlock Tower (including the Urology clinic at MEDVAMC) and local prostate cancer-support groups
    • Prostate cancer survivors who participated in the US TOO Father's Day Walk/Run or the Gay Pride Celebration

PATIENT CHARACTERISTICS:

  • Able to speak and read in English
  • Willing to review the written patient educational materials and discuss them in a group setting

PRIOR CONCURRENT THERAPY:

  • See Disease Characteristics
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00769431

Locations
United States, Texas
Dan L. Duncan Cancer Center at Baylor College of Medicine
Houston, Texas, United States, 77030
Veterans Affairs Medical Center - Houston
Houston, Texas, United States, 77030
Sponsors and Collaborators
Baylor College of Medicine
Investigators
Principal Investigator: David Latini, PhD Baylor College of Medicine
  More Information

Additional Information:
No publications provided

Responsible Party: Dan L. Duncan Cancer Center at Baylor College of Medicine ( David Latini )
Study ID Numbers: CDR0000600594, BCM-H-21622
Study First Received: October 8, 2008
Last Updated: May 1, 2009
ClinicalTrials.gov Identifier: NCT00769431     History of Changes
Health Authority: United States: Federal Government

Keywords provided by National Cancer Institute (NCI):
stage I prostate cancer
stage II prostate cancer

Study placed in the following topic categories:
Prostatic Diseases
Genital Neoplasms, Male
Urogenital Neoplasms
Genital Diseases, Male
Prostatic Neoplasms

Additional relevant MeSH terms:
Neoplasms
Neoplasms by Site
Prostatic Diseases
Genital Neoplasms, Male
Urogenital Neoplasms
Genital Diseases, Male
Prostatic Neoplasms

ClinicalTrials.gov processed this record on May 07, 2009